Literature DB >> 19097173

Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab.

Joshua Ruch1, Brandon McMahon, Glenn Ramsey, Hau C Kwaan.   

Abstract

Cold agglutinin disease occurring with cryoglobulinemia is a rare occurrence. Here, we report a patient with mixed cryoglobulinemia that was treated with rituximab and, after response, developed an anti-Pr cold agglutinin that manifested with hemolysis and microvascular occlusion causing mesenteric ischemia and cerebral infarction. Unlike previous reports of patients with cryoglobulinemia and cold agglutinin disease, our patient did not have a detectable cryoprecipitate when his cold agglutinin manifested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19097173     DOI: 10.1002/ajh.21330

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  [Rheumatoid arthritis and autoimmune hemolysis: B-cell depletion for remission induction in a patient with rheumatoid arthritis and cold agglutinin disease].

Authors:  P Lehmann; W Hartung; B Ehrenstein; J Schölmerich; M Fleck
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

2.  Rituximab therapy for primary glomerulonephritis: Report on two cases.

Authors:  Fabrizio Fabrizi; Donata Cresseri; Giovanni B Fogazzi; Gabriella Moroni; Patrizia Passerini; Paul Martin; Piergiorgio Messa
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

Review 3.  Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.

Authors:  Freke Wink; Pieternella M Houtman; Tim L Th A Jansen
Journal:  Clin Rheumatol       Date:  2010-10-31       Impact factor: 3.650

Review 4.  Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.

Authors:  Brian A Baldo
Journal:  Oncoimmunology       Date:  2013-10-17       Impact factor: 8.110

5.  Fatal massive hemolysis caused by immunoglobulin M anti-c antibody in a patient with newly diagnosed B-cell acute lymphoblastic leukemia: a case report.

Authors:  Carlos Galvez; Abdulrahman Abutaleb; Wade T Iams; Paul F Lindholm; Hau C Kwaan
Journal:  Clin Case Rep       Date:  2018-04-17

6.  Eculizumab as a bridge to immunosuppressive therapy in severe cold agglutinin disease of anti-Pr specificity.

Authors:  Roman Shapiro; Ian Chin-Yee; Selay Lam
Journal:  Clin Case Rep       Date:  2015-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.